- Home
- VVOS vs RDI Comparison
VVOS vs RDI Comparison
Compare VVOS & RDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VVOS
- RDI
- Stock Information
- Founded
- VVOS 2016
- RDI 1937
- Country
- VVOS United States
- RDI United States
- Employees
- VVOS N/A
- RDI N/A
- Industry
- VVOS Medical Specialities
- RDI Movies/Entertainment
- Sector
- VVOS Health Care
- RDI Consumer Discretionary
- Exchange
- VVOS Nasdaq
- RDI Nasdaq
- Market Cap
- VVOS 27.3M
- RDI 27.9M
- IPO Year
- VVOS 2020
- RDI N/A
- Fundamental
- Price
- VVOS $4.11
- RDI $1.40
- Analyst Decision
- VVOS Strong Buy
- RDI
- Analyst Count
- VVOS 2
- RDI 0
- Target Price
- VVOS $6.10
- RDI N/A
- AVG Volume (30 Days)
- VVOS 176.0K
- RDI 52.3K
- Earning Date
- VVOS 08-26-2025
- RDI 08-14-2025
- Dividend Yield
- VVOS N/A
- RDI N/A
- EPS Growth
- VVOS N/A
- RDI N/A
- EPS
- VVOS N/A
- RDI N/A
- Revenue
- VVOS $14,628,000.00
- RDI $219,213,000.00
- Revenue This Year
- VVOS $3.83
- RDI $7.47
- Revenue Next Year
- VVOS $25.27
- RDI $13.22
- P/E Ratio
- VVOS N/A
- RDI N/A
- Revenue Growth
- VVOS 9.47
- RDI 7.59
- 52 Week Low
- VVOS $1.98
- RDI $1.17
- 52 Week High
- VVOS $7.95
- RDI $1.89
- Technical
- Relative Strength Index (RSI)
- VVOS 41.25
- RDI 56.96
- Support Level
- VVOS $4.31
- RDI $1.33
- Resistance Level
- VVOS $4.81
- RDI $1.47
- Average True Range (ATR)
- VVOS 0.50
- RDI 0.06
- MACD
- VVOS -0.12
- RDI 0.01
- Stochastic Oscillator
- VVOS 19.68
- RDI 70.83
About VVOS Vivos Therapeutics Inc.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
About RDI Reading International Inc
Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial and live theater assets.